| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 12.75▼ | 12.78▼ | 12.78▼ | 12.90▼ | 13.05▼ |
| MA10 | 12.77▼ | 12.83▼ | 12.84▼ | 13.00▼ | 13.07▼ |
| MA20 | 12.80▼ | 12.88▼ | 12.89▼ | 13.06▼ | 13.09▼ |
| MA50 | 12.89▼ | 12.96▼ | 13.00▼ | 13.12▼ | 13.11▼ |
| MA100 | 13.00▼ | 13.07▼ | 13.07▼ | 13.09▼ | 12.90▼ |
| MA200 | 13.07▼ | 13.15▼ | 13.11▼ | 13.12▼ | 12.46▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▲ | -0.012▼ | -0.012▼ | -0.032▼ | -0.031▼ |
| RSI | 24.172▼ | 25.519▼ | 25.480▼ | 31.556▼ | 43.422▼ |
| STOCH | 8.333▼ | 0.000▼ | 16.667▼ | 10.053▼ | 39.906 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -100.000▼ | -100.000▼ |
| CCI | -109.073▼ | -120.768▼ | -135.106▼ | -162.384▼ | -154.760▼ |
|
Monday, February 09, 2026 07:32 AM
(RTTNews) - Biofrontera Inc. (BFRI) announced positive and statistically significant top-line results from its Phase 3 clinical trial evaluating Ameluz photodynamic therapy (PDT) with RhodoLED ...
|
|
Monday, February 09, 2026 06:46 AM
(RTTNews) - Biofrontera Inc. (BFRI), Monday announced positive and statistically significant top-line results from its Phase 3 clinical trial, evaluating Ameluz PDT with the red-light LEDplatform for ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/05/26 | 12.83 | 12.83 | 12.745 | 12.745 | 62,498 |
| 14/05/26 | 12.88 | 12.95 | 12.88 | 12.93 | 152,380 |
| 13/05/26 | 12.93 | 12.95 | 12.86 | 12.91 | 99,192 |
| 12/05/26 | 12.97 | 12.9999 | 12.9319 | 12.96 | 95,279 |
| 11/05/26 | 12.97 | 13.00 | 12.9473 | 12.97 | 74,749 |
| 08/05/26 | 13.03 | 13.05 | 12.9701 | 13.05 | 108,579 |
| 07/05/26 | 13.13 | 13.13 | 12.95 | 12.97 | 138,032 |
| 06/05/26 | 13.25 | 13.28 | 13.09 | 13.12 | 146,830 |
| 05/05/26 | 13.17 | 13.22 | 13.14 | 13.18 | 136,303 |
| 04/05/26 | 13.23 | 13.2995 | 13.13 | 13.17 | 140,514 |
|
|
||||
|
|
||||
|
|